stockrow
Friday 6 November 2026
Export SCL’s income statement to Excel — free account
Stepan Company
SCL Basic Materials Specialty Chemicals
Stepan Company’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.96% from fiscal 2024.
- Revenue
- +17.3%
- EPS
- +65.5%
- Free cash flow
- −4.42%
- Total debt
- −47.9%
Quarter to September 2026, against a year earlier
66.83
1.02
−1.50%
Follow SCL
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
332.34 | 0.00 | 0.00 | 23.10 |
+8 more quarters Free account |
P/S ratio |
0.56 | 0.52 | 0.49 | 0.46 | |
P/FCF ratio |
21.51 | 19.20 | 17.06 | 19.62 | |
P/Operating CF |
170.84 | 152.54 | 67.55 | 18.06 | |
P/B ratio |
1.18 | 1.05 | 0.96 | 0.87 | |
Price to Tangible BV |
1.32 | 1.18 | 1.08 | 0.97 | |
EV/Sales |
0.81 | 0.74 | 0.71 | 0.68 | |
EV/EBITDA |
13.80 | 12.13 | 12.70 | 7.71 | |
EV/Operating CF |
13.29 | 11.67 | 10.48 | 10.67 | |
EV/FCF |
31.01 | 27.24 | 24.67 | 28.56 | |
Quick Ratio |
0.00 | 0.72 | 0.80 | 0.78 | |
Current Ratio |
1.32 | 1.15 | 1.26 | 1.29 | |
Net Debt/EBITDA |
0.00 | 7.83 | (30.64) | 11.43 | |
Debt/Assets |
14.29% | 27.06% | 27.93% | 26.58% | |
Debt/Equity |
0.28 | 0.53 | 0.55 | 0.50 | |
Asset Turnover |
1.05 | 1.01 | 0.99 | 1.00 | |
Operating CF/Net income |
0.00 | 0.37 | (0.41) | 11.99 | |
Capex/Depreciation |
— | (0.76) | (0.94) | (0.25) | |
Interest Coverage |
4.09 | 6.55 | (9.90) | 1.85 | |
Research and Development Expense of Revenue |
2.26% | 2.51% | 2.48% | 2.84% | |
Selling, General and Administrative Expense of Revenue |
5.83% | 5.92% | 5.63% | 6.31% | |
Intangible Assets out of Total Assets |
0.00 | 0.05 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
0.00% | 0.31% | 0.25% | 0.28% | |
Graham Net Nets |
(0.13) | (0.16) | (0.20) | (0.24) | |
Graham Number |
0.00 | 0.00 | 0.00 | 50.09 | |
Earnings Yield |
0.30% | (0.22%) | (1.24%) | 4.33% | |
Free Cash Flow Yield |
4.65% | 5.21% | 5.86% | 5.10% | |
Revenue per Share |
30.22 | 29.88 | 26.41 | 24.22 | |
Operating CF per Share |
0.00 | 0.37 | 0.74 | 2.62 | |
Capex per Share |
0.00 | (1.02) | (1.35) | (0.35) | |
Free Cash Flow per Share |
0.00 | (0.66) | (0.61) | 2.27 | |
Cash per Share |
0.00 | 4.97 | 6.15 | 5.80 | |
Shareholders Equity per Share |
53.21 | 52.93 | 52.12 | 54.39 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
53.21 | 52.93 | 52.12 | 54.39 | |
Free Cash Flow |
— | (15.04) | (13.95) | 51.96 | |
Working Capital |
239.79 | 127.77 | 185.79 | 192.47 | |
Capital Expenditures |
— | (23.41) | (30.89) | (8.03) | |
Net Current Asset Value |
(188.85) | (205.86) | (234.07) | (254.73) | |
EV/EBIT |
85.67 | 91.00 | 2,591.03 | 20.08 | |
Capex to Sales |
0.00 | 0.03 | 0.05 | 0.01 | |
Price to Operating Income |
59.42 | 64.16 | 1,790.77 | 13.79 | |
| Other line items | |||||
Average Receivables |
— | 467.25 | 435.09 | 387.99 | |
Average Payables |
— | 301.71 | 291.92 | 260.26 | |
Average Inventory |
— | 326.97 | 299.17 | 293.77 | |
Average Assets |
2,411.34 | 2,404.40 | 2,361.51 | 2,331.18 | |
Average Common Equity |
— | 1,226.88 | 1,196.78 | 1,206.97 |
Columns are period end dates · fundamentals updated 2 Nov 2026